Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T11:08:01.417Z Has data issue: false hasContentIssue false

Mobile Decontamination Units—Room for Improvement?

Published online by Cambridge University Press:  06 August 2012

Pascale Ribordy*
Affiliation:
Section of Emergency Medicine, Södersjukhuset, Stockholm, Sweden
David Rocksén
Affiliation:
Experimental Traumatology Unit, Department of Neuroscience, Karolinska Institute at Karolinska University Hospital, Stockholm, Sweden
Uno Dellgar
Affiliation:
UD Consulting AB, Järfälla, Sweden
Sven-Åke Persson
Affiliation:
FOI CBRN-Defense and Security, Umeå, Sweden
Kristina Arnoldsson
Affiliation:
FOI CBRN-Defense and Security, Umeå, Sweden
Hans Ekåsen
Affiliation:
Swedish Rescue Services Agency, Karlstad, Sweden
Sune Häggbom
Affiliation:
AB Sunda Hus, Täby, Sweden
Ola Nerf
Affiliation:
Section of Emergency Medicine, Södersjukhuset, Stockholm, Sweden
Åsa Ljungqvist
Affiliation:
National Board of Health and Welfare, Stockholm, Sweden
Dan Gryth
Affiliation:
Department of Clinical Science and Education, Section of Emergency Medicine, Karolinska Institute, Stockholm, Sweden Department of Physiology and Pharmacology, Section of Anesthesiology and Intensive Care, Karolinska Institute, Stockholm, Sweden
Ola Claesson
Affiliation:
FOI CBRN-Defense and Security, Umeå, Sweden
*
Correspondence: Pascale Ribordy, MSc Stockholm's Prehospital Center Södersjukhuset / South Stockholm Hospital S-118 83 Stockholm, Sweden E-mail pascale.ribordy@gmail.com
Rights & Permissions [Opens in a new window]

Abstract

Introduction

Mobile decontamination units are intended to be used at the accident site to decontaminate persons contaminated by toxic substances. A test program was carried out to evaluate the efficacy of mobile decontamination units.

Objective

The tests included functionality, methodology, inside environment, effects of wind direction, and decontamination efficacy.

Methods

Three different types of units were tested during summer and winter conditions. Up to 15 test-persons per trial were contaminated with the imitation substances Purasolve ethyl lactate (PEL) and methyl salicylate (MES). Decontamination was carried out according to standardized procedures. During the decontamination trials, the concentrations of the substances inside the units were measured. After decontamination, substances evaporating from test-persons and blankets as well as remaining amounts in the units were measured.

Results

The air concentrations of PEL and MES inside the units during decontamination in some cases exceeded short-term exposure limits for most toxic industrial chemicals. This was a problem, especially during harmful wind conditions, i.e., wind blowing in the same direction as persons moving through the decontamination units. Although decontamination removed a greater part of the substances from the skin, the concentrations evaporating from some test-persons occasionally were high and potentially harmful if the substances had been toxic. The study also showed that blankets placed in the units absorbed chemicals and that the units still were contaminated five hours after the end of operations.

Conclusions

After decontamination, the imitation substances still were present and evaporating from the contaminated persons, blankets, and units. These results indicate a need for improvements in technical solutions, procedures, and training.

RibordyP , RocksénD , DellgarU , PerssonS , ArnoldssonK , EkåsenH , HäggbomS , NerfO , LjungqvistA , GrythD , ClaessonO . Mobile Decontamination Units—Room for Improvement?. Prehosp Disaster Med.2012;27(4):1–7.

Information

Type
Original Research
Copyright
Copyright © World Association for Disaster and Emergency Medicine 2012
Figure 0

Table 1 Comparison of the Three Decontamination Units in Terms of Number of Personnel, Number Decontaminated per Hour, Air and Water Temperature

Figure 1

Table 2 Average Concentrations and Variations of Purasolve Ethyl Lactate and Methyl Salicylate in the Three Decontamination Units During the Winter and Summer Trialsa

Figure 2

Figure 1 Concentrations of PEL (Figure 1(a)) and MES (Figure 1(b)) in the SEDAB Tent During the Summer Trials with Useful and Harmful WindAbbreviations: MES, methyl salicylate; PEL, Purasolve ethyl lactate; SEDAB, Safety Equipment Development AB.

Figure 3

Figure 2 Concentrations of PEL (Figure 2(a)) and MES (Figure 2(b)) Evaporating from Test-Persons During 10 Minutes, 50 Minutes Following Decontamination During the Winter Trials. The short-term exposure limit for chlorine (15 minutes) and the acute exposure guideline for mustard gas (one hour18) are indicated in the figures.Abbreviations: MES, methyl salicylate; PEL, Purasolve ethyl lactate; SEDAB, Safety Equipment Development AB.

Figure 4

Figure 3 Estimated Total Amount of PEL and MES Absorbed by the Blanket Placed in the Decontamination Units During the Summer TrialsAbbreviations: HW, harmful wind; MES, methyl salicylate; PEL, Purasolve ethyl lactate; SEDAB, Safety Equipment Development AB.

Figure 5

Figure 4 Concentration of PEL (Figure 4(a)) and MES (Figure 4(b)) in the Units Up to 15 Hours After End of Decontamination During Winter and Summer Trials. No values were available for 15-hour winter trials.Abbreviations: MES, methyl salicylate; PEL, Purasolve ethyl lactate; SEDAB, Safety Equipment Development AB.